ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS

Manylion Llyfryddiaeth
Prif Awduron:	Feldmann, M, Brennan, F, Williams, R, Monaco, C, Maini, R
Fformat:	Conference item
Cyhoeddwyd:	2011

Eitemau Tebyg

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
gan: Maini, R, et al.
Cyhoeddwyd: (1993)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1994)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
gan: Maini, R, et al.
Cyhoeddwyd: (1997)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
gan: Maini, R, et al.
Cyhoeddwyd: (2000)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (2004)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1995)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
gan: Feldmann, M, et al.
Cyhoeddwyd: (2001)

TNFα - A pivotal role in rheumatoid arthritis?
gan: Brennan, F, et al.
Cyhoeddwyd: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
gan: Brennan, F, et al.
Cyhoeddwyd: (1992)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1995)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (2001)

Development of anti-TNF therapy for rheumatoid arthritis.
gan: Feldmann, M
Cyhoeddwyd: (2002)

TNF alpha as a therapeutic target in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1994)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
gan: Taylor, P, et al.
Cyhoeddwyd: (2000)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1992)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
gan: Feldmann, M, et al.
Cyhoeddwyd: (1994)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
gan: Maini, R, et al.
Cyhoeddwyd: (1995)

Rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1996)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
gan: Maini, R, et al.
Cyhoeddwyd: (1995)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
gan: Taylor, P, et al.
Cyhoeddwyd: (2009)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1997)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
gan: Feldmann, M, et al.
Cyhoeddwyd: (2003)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
gan: Brennan, F, et al.
Cyhoeddwyd: (1989)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1994)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
gan: Williams, R, et al.
Cyhoeddwyd: (2000)

Role of cytokines in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1996)

Cytokine therapy in rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1996)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
gan: Feldmann, M, et al.
Cyhoeddwyd: (2002)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
gan: Feldmann, M, et al.
Cyhoeddwyd: (2002)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
gan: Elliott, M, et al.
Cyhoeddwyd: (1995)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
gan: Elliott, M, et al.
Cyhoeddwyd: (1995)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
gan: Feldman, M, et al.
Cyhoeddwyd: (1998)

Anti-TNF therapy: where have we got to in 2005?
gan: Feldmann, M, et al.
Cyhoeddwyd: (2005)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1997)

Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis.
gan: Butler, D, et al.
Cyhoeddwyd: (1999)

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
gan: Feldmann, M, et al.
Cyhoeddwyd: (2004)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
gan: Brennan, F, et al.
Cyhoeddwyd: (1998)

Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.
gan: Williams, R, et al.
Cyhoeddwyd: (1995)

Cytokine expression in rheumatoid arthritis.
gan: Brennan, F, et al.
Cyhoeddwyd: (1991)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
gan: Charles, P, et al.
Cyhoeddwyd: (1999)